Native and oxidized low density lipoproteins enhance platelet aggregation in whole blood

Thrombosis Research

Volumn 95, Issue 4, 1999, Pages 177-183

  Tornvall, Per ^a,b   Chirkova, Larissa ^a   Toverud, Karin Danell ^b   Horowitz, John D ^a   Chirkov, Yuliy ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Native LDL; Oxidized LDL; Platelet aggregation; Whole blood

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ANGINA PECTORIS; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY; THROMBOCYTE AGGREGATION;

ADULT; AGED; ANALYSIS OF VARIANCE; ANGINA PECTORIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PLATELET AGGREGATION; PLATELET COUNT;

EID: 0032881509     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00036-5     Document Type: Article

References (25)

1. Tremoli E., Colli S., Maderna P., Baldassarre D., Di Minno G. Hypercholesterolemia and platelets. Sem Thromb Hemostasis. 19:1993;115-121.
2. Mosconi C., Colli S., Tremoli E., Galli C. Phosphatidylinositol (PI) and PI-associated arachidonate are elevated in platelet total membranes of type IIa hypercholesterolemic subjects. Atherosclerosis. 72:1988;129-134.
3. Chetty N., Naran N.H. Platelet hyperreactivity in hyperlipidaemia with specific reference to platelet lipids and fatty acid composition. Clin Chim Acta. 213:1992;1-13.
4. Shattil S.J., Anaya-Galindo R., Bennett J., Colman R.W., Cooper R.A. Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest. 55:1975;636-643.
5. Surya I.I., Akkerman J.-W.N. The influence of lipoproteins on blood platelets. Am Heart J. 125:1993;272-275.
6. Ardlie N.G., Selley M.L., Simons L.A. Platelet activation by oxidatively modified low density lipoproteins. Atherosclerosis. 76:1989;117-124.
7. Aviram M. Modified forms of low density lipoprotein affect platelet aggregation in vitro. Thromb Res. 53:1989;561-567.
8. Aviram M. Malondialdehyde affects the physico-chemical and biological characteristics of oxidized low density lipoprotein. Atherosclerosis. 84:1990;141-143.
9. Meraji S., Moore C.E., Skinner V.O., Bruckdorfer K.R. The importance of oxidation or glycosylation of low-density lipoproteins in relation to platelet activation. Platelets. 3:1992;155-162.
10. Zhao B., Dierichs R., Liu B., Holling-Rauß B. Functional morphological alterations of human blood platelets induced by oxidized low density lipoprotein. Thromb Res. 74:1994;293-301.
11. Malle E., Ibovnik A., Leis H.J., Kostner G.M., Verhallen P.F.J., Sattler W. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation. Arterioscler Thromb Vasc Biol. 15:1995;377-384.
12. 2. Arterioscler Thromb Vasc Biol. 15:1995;1131-1138.
13. Naseem K.M., Goodall A.H., Bruckdorfer K.R. Differential effects of native and oxidatively modified low-density lipoprotein on platelet function. Platelets. 8:1997;163-173.
14. Redgrave T.G., Carlsson L.A. Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man. J Lipid Res. 20:1979;217-229.
15. Rumsey S.C., Stucchi A.F., Nicolosi R.J., Ginsberg H.N., Ramakrishnan R., Deckelbaum R.J. Human plasma LDL cryopreserved with sucrose maintains in vivo kinetics indistinguishable from freshly isolated human LDL in cynomolgus monkeys. J Lipid Res. 35:1994;1592-1598.
16. Steinbrecher U.P. Oxidation of human low density lipoproteins results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem. 262:1987;3603-3608.
17. Esterbauer H., Striegl G., Puhl G., Rothender M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 6:1989;67-75.
18. Yagi K., Nishigaki I., Ohama H. Measurement of serum TBA-value. Vitamins. 37:1968;105-112.
19. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-268.
20. Bröijersén A., Wallén N.H., Vitols S., Larsson P.T., Hjemdahl P. Autologous low density lipoprotein enhances platelet aggregation in whole blood, as measured by in vitro filtragometry. Platelets. 4:1993;11-15.
21. Chirkov Y.Y., Naujalis J.I., Sage R.E., Horowitz J.D. Antiplatelet effects of nitroglycerin in healthy subjects and in patients with stable angina pectoris. J Cardiovasc Pharmacol. 21:1993;384-389.
22. Regnström J., Ström K., Moldeus P., Nilsson J. Analysis of lipoprotein diene formation inhuman serum exposed to copper. Free Radic Res Commun. 19:1993;267-278.
23. Lehr H.A., Krombach F., Munzing S., Bodlaj R., Glaubitt S.I., Seiffge D., Hubner C., von Andrian U.H., Messmer K. In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation. Am J Pathol. 146:1995;218-227.
24. Bonneau C., Couderc R., Tissot M., Athias A., Roch-Arveiller M., Giroud J.P. Effects of human low density lipoproteins on superoxide production by fMPL activated polymorphonuclear leukocytes. Eur J Clin Chem Clin Biochem. 35:1997;73-80.
25. Iuliano L., Colavita A.R., Leo R., Pratico D., Violi F. Oxygen free radicals and platelet activation. Free Radic Biol Med. 22:1997;999-1006.